Literature DB >> 12184542

Helicobacter pylori prevents proliferative stage of angiogenesis in vitro: role of cytokines.

Lesley Jenkinson1, Karna Dev Bardhan, John Atherton, Neena Kalia.   

Abstract

Inhibition of angiogenesis may explain the delayed ulcer healing following Helicobacter pylori infection. We have previously demonstrated that H. pylori can inhibit endothelial cell proliferation. Some cytokines possess antiangiogenic properties. This study assessed a role for IL-6, IL-8, and TNF-a in H. pylori-induced endothelial cytostasis. First, 30 microl of H. pylori was coincubated with microvascular endothelial cells in the presence or absence of monoclonal antibodies to IL-6, IL-8, and TNF-a for 24, 48, 72, or 96 hr. Dual labeling with propidium iodide and Hoescht 33342 distinguished between necrosis, and apoptosis and allowed viable cell numbers to be determined. H. pylori decreased cell viability after 72 and 96 hr (P < 0.02). Neither necrosis nor apoptosis was observed. Monoclonal antibodies to IL-6 and IL-8 did not reverse cytostasis. However, significant MVEC proliferation was observed in the presence of the TNF-a monoclonal antibody. In conclusion, H. pylori induces cytokine up-regulation as part of its pathophysiological mechanism, which could prove detrimental to ulcer healing through an inhibitory effect on angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12184542     DOI: 10.1023/a:1016469217449

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Effects of genotypically different strains of Helicobacter pylori on human microvascular endothelial cells in vitro.

Authors:  N Kalia; C Jones; D K Bardhan; M W Reed; J C Atherton; N J Brown
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 2.  Angiogenesis in wound healing.

Authors:  F Arnold; D C West
Journal:  Pharmacol Ther       Date:  1991-12       Impact factor: 12.310

3.  Water extracts of Helicobacter pylori delay healing of chronic gastric ulcers in rats: role of cytokines and gastrin-somatostatin link.

Authors:  T Brzozowski; P C Konturek; S J Konturek; S Kwiecien; R Pajdo; E Karczewska; J Stachura; E G Hahn
Journal:  Digestion       Date:  1999 Jan-Feb       Impact factor: 3.216

4.  Bacterial toxins block endothelial wound repair. Evidence that Rho GTPases control cytoskeletal rearrangements in migrating endothelial cells.

Authors:  M Aepfelbacher; M Essler; E Huber; M Sugai; P C Weber
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-09       Impact factor: 8.311

Review 5.  Angiogenesis-regulating cytokines: activities and interactions.

Authors:  M S Pepper; S J Mandriota; J D Vassalli; L Orci; R Montesano
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

6.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

Authors:  M Fràter-Schröder; W Risau; R Hallmann; P Gautschi; P Böhlen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  The effect of local infection upon wound healing: an experimental study.

Authors:  T E Bucknall
Journal:  Br J Surg       Date:  1980-12       Impact factor: 6.939

Review 8.  Helicobacter pylori.

Authors:  B J Marshall
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

9.  Angiogenesis: initiation and control.

Authors:  J Folkman
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

10.  Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs.

Authors:  N Hudson; M Balsitis; S Everitt; C J Hawkey
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

View more
  3 in total

1.  Agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma): a new compound with potent gastroprotective and ulcer healing properties.

Authors:  Tomasz Brzozowski; Peter C Konturek; Robert Pajdo; Slawomir N Kwiecień; Stanislaw Konturek; Aneta Targosz; Grzegorz Burnat; Jakub Cieszkowski; Wieslaw W Pawlik; Eckhart G Hahn
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

2.  Angiogenesis: Future of pharmacological modulation.

Authors:  Manisha Bisht; D C Dhasmana; S S Bist
Journal:  Indian J Pharmacol       Date:  2010-02       Impact factor: 1.200

Review 3.  Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine.

Authors:  Markus Stein; Paolo Ruggiero; Rino Rappuoli; Fabio Bagnoli
Journal:  Front Immunol       Date:  2013-10-15       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.